Adeno-associated viral vector-mediated transgene expression is independent of dna methylation in primate liver and skeletal muscle

PLoS ONE

Volumn 6, Issue 6, 2011, Pages

  Léger, Adrien ^a   Guiner, Caroline ^a,b   Nickerson, Michael L ^c   Im, Kate ^c   Ferry, Nicolas ^a   Moullier, Philippe ^a,b,d   Snyder, Richard O ^a,d,e   Penaud Budloo, Magalie ^a  

^a INSERM   (France)

^b GÉNÉTHON   (France)

^c NATIONAL CANCER INSTITUTE   (United States)

^d UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PARVOVIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CPG ISLAND; DNA DETERMINATION; DNA ISOLATION; DNA METHYLATION; GENE CASSETTE; GENE EXPRESSION REGULATION; GENE REPRESSION; GENE TRANSFER; LIVER; MOUSE; NONHUMAN; PRIMATE; PROMOTER REGION; ROUS SARCOMA ONCOVIRUS; SKELETAL MUSCLE; TRANSCRIPTION REGULATION; TRANSGENE; VIRION; VIRUS CELL INTERACTION; VIRUS RECOMBINANT; ADENO ASSOCIATED VIRUS; ANIMAL; GENE EXPRESSION; GENE VECTOR; GENETICS; MACACA FASCICULARIS; METABOLISM;

MAMMALIA; PRIMATES; ROUS SARCOMA VIRUS;

ANIMALS; DEPENDOVIRUS; DNA METHYLATION; GENE EXPRESSION; GENETIC VECTORS; LIVER; MACACA FASCICULARIS; MUSCLE, SKELETAL; PROMOTER REGIONS, GENETIC; ROUS SARCOMA VIRUS; TRANSGENES;

EID: 79958138516     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0020881     Document Type: Article

References (53)

1. Favre D, Blouin V, Provost N, Spisek R, Porrot F, et al. (2002) Lack of an immune response against the tetracycline-dependent transactivator correlates with long-term doxycycline-regulated transgene expression in nonhuman primates after intramuscular injection of recombinant adeno-associated virus. J Virol 76: 11605-11611.
2. Toromanoff A, Chérel Y, Guilbaud M, Penaud-Budloo M, Snyder RO, et al. (2008) Safety and efficacy of regional intravenous (r.i.) versus intramuscular (i.m.) delivery of rAAV1 and rAAV8 to nonhuman primate skeletal muscle. Mol Ther 16: 1291-1299.
3. Rivera VM, Gao G, Grant RL, Schnell MA, Zoltick PW, et al. (2005) Long-term pharmacologically regulated expression of erythropoietin in primates following AAV-mediated gene transfer. Blood 105: 1424-1430.
4. Penaud-Budloo M, Le Guiner C, Nowrouzi A, Toromanoff A, Chérel Y, et al. (2008) Adeno-associated virus vector genomes persist as episomal chromatin in primate muscle. J Virol 82: 7875-7885.
5. Lu Y, Choi Y, Campbell-Thompson M, Li C, Tang Q, et al. (2006) Therapeutic level of functional human alpha 1 antitrypsin (hAAT) secreted from murine muscle transduced by adeno-associated virus (rAAV1) vector. J Gene Med 8: 730-735.
6. Herzog RW, Hagstrom JN, Kung SH, Tai SJ, Wilson JM, et al. (1997) Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus. Proc Natl Acad Sci U S A 94: 5804-5809.
7. Fisher KJ, Jooss K, Alston J, Yang Y, Haecker SE, et al. (1997) Recombinant adeno-associated virus for muscle directed gene therapy. Nat Med 3: 306-312.
8. Ferrari FK, Samulski T, Shenk T, Samulski RJ, (1996) Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors. J Virol 70: 3227-3234.
9. Ding W, Zhang L, Yan Z, Engelhardt JF, (2005) Intracellular trafficking of adeno-associated viral vectors. Gene Ther 12: 873-880.
10. Sun X, Lu Y, Bish LT, Calcedo R, Wilson JM, et al. (2010) Molecular analysis of vector genome structures after liver transduction by conventional and self-complementary adeno-associated viral serotype vectors in murine and nonhuman primate models. Hum Gene Ther 21: 750-761.
11. McCarty DM, Young SM, Samulski RJ, (2004) Integration of adeno-associated virus (AAV) and recombinant AAV vectors. Annu Rev Genet 38: 819-845.
12. Lieberman PM, (2006) Chromatin regulation of virus infection. Trends Microbiol 14: 132-140.
13. Paulus C, Nitzsche A, Nevels M, (2010) Chromatinisation of herpesvirus genomes. Rev Med Virol 20: 34-50.
14. Li B, Carey M, Workman JL, (2007) The role of chromatin during transcription. Cell 128: 707-719.
15. Miranda TB, Jones PA, (2007) DNA methylation: the nuts and bolts of repression. J Cell Physiol 213: 384-390.
16. Klose RJ, Bird AP, (2006) Genomic DNA methylation: the mark and its mediators. Trends Biochem Sci 31: 89-97.
17. Cedar H, Bergman Y, (2009) Linking DNA methylation and histone modification: patterns and paradigms. Nat Rev Genet 10: 295-304.
18. Ellis J, (2005) Silencing and variegation of gammaretrovirus and lentivirus vectors. Hum Gene Ther 16: 1241-1246.
19. Lorincz MC, Schübeler D, Goeke SC, Walters M, Groudine M, et al. (2000) Dynamic analysis of proviral induction and De Novo methylation: implications for a histone deacetylase-independent, methylation density-dependent mechanism of transcriptional repression. Mol Cell Biol 20: 842-850.
20. Hodges BL, Taylor KM, Joseph MF, Bourgeois SA, Scheule RK, (2004) Long-term transgene expression from plasmid DNA gene therapy vectors is negatively affected by CpG dinucleotides. Mol Ther 10: 269-278.
21. Hong K, Sherley J, Lauffenburger DA, (2001) Methylation of episomal plasmids as a barrier to transient gene expression via a synthetic delivery vector. Biomol Eng 18: 185-192.
22. Riu E, Chen Z, Xu H, He C, Kay MA, (2007) Histone modifications are associated with the persistence or silencing of vector-mediated transgene expression in vivo. Mol Ther 15: 1348-1355.
23. Chen Z, Riu E, He C, Xu H, Kay MA, (2008) Silencing of episomal transgene expression in liver by plasmid bacterial backbone DNA is independent of CpG methylation. Mol Ther 16: 548-556.
24. Hoelzer K, Shackelton LA, Parrish CR, (2008) Presence and role of cytosine methylation in DNA viruses of animals. Nucleic Acids Res 36: 2825-2837.
25. Reed K, Poulin ML, Yan L, Parissenti AM, (2010) Comparison of bisulfite sequencing PCR with pyrosequencing for measuring differences in DNA methylation. Anal Biochem 397: 96-106.
26. Tost J, Gut IG, (2007) DNA methylation analysis by pyrosequencing. Nat Protoc 2: 2265-2275.
27. Dupont J, Tost J, Jammes H, Gut IG, (2004) De novo quantitative bisulfite sequencing using the pyrosequencing technology. Anal Biochem 333: 119-127.
28. Potapova A, Albat C, Hasemeier B, Hauszler K, Lamprecht S, et al. (2011) Systematic cross-validation of 454 sequencing and pyrosequencing for the exact quantification of DNA methylation patterns with single CpG resolution. BMC Biotechnol 11: 6.
29. Takai D, Jones PA, (2002) Comprehensive analysis of CpG islands in human chromosomes 21 and 22. Proc Natl Acad Sci U S A 99: 3740-3745.
30. Takai D, Jones PA, (2003) The CpG island searcher: a new WWW resource. In Silico Biol (Gedrukt) 3: 235-240.
31. Weber M, Hellmann I, Stadler MB, Ramos L, Pääbo S, et al. (2007) Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome. Nat Genet 39: 457-466.
32. Hsieh CL, (1997) Stability of patch methylation and its impact in regions of transcriptional initiation and elongation. Mol Cell Biol 17: 5897-5904.
33. Hejnar J, Hájková P, Plachy J, Elleder D, Stepanets V, et al. (2001) CpG island protects Rous sarcoma virus-derived vectors integrated into nonpermissive cells from DNA methylation and transcriptional suppression. Proc Natl Acad Sci U S A 98: 565-569.
34. Katz RA, Mitsialis SA, Guntaka RV, (1983) Studies on the methylation of avian sarcoma proviruses in permissive and non-permissive cells. J Gen Virol 64 (Pt 2): 429-435.
35. Lizée G, Aerts JL, Gonzales MI, Chinnasamy N, Morgan RA, et al. (2003) Real-time quantitative reverse transcriptase-polymerase chain reaction as a method for determining lentiviral vector titers and measuring transgene expression. Hum Gene Ther 14: 497-507.
36. Ahn K, Huh J, Park S, Kim D, Ha H, et al. (2008) Selection of internal reference genes for SYBR green qRT-PCR studies of rhesus monkey (Macaca mulatta) tissues. BMC Mol Biol 9: 78.
37. Nishimura M, Koeda A, Suganuma Y, Suzuki E, Shimizu T, et al. (2007) Comparison of inducibility of CYP1A and CYP3A mRNAs by prototypical inducers in primary cultures of human, cynomolgus monkey, and rat hepatocytes. Drug Metab Pharmacokinet 22: 178-186.
38. Salvetti A, Orève S, Chadeuf G, Favre D, Cherel Y, et al. (1998) Factors influencing recombinant adeno-associated virus production. Hum Gene Ther 9: 695-706.
39. Droege M, Hill B, (2008) The Genome Sequencer FLX System-longer reads, more applications, straight forward bioinformatics and more complete data sets. J Biotechnol 136: 3-10.
40. Ishida T, Hamano A, Koiwa T, Watanabe T, (2006) 5′ long terminal repeat (LTR)-selective methylation of latently infected HIV-1 provirus that is demethylated by reactivation signals. Retrovirology 3: 69.
41. Huang X, Yang Y, (2009) Innate immune recognition of viruses and viral vectors. Hum Gene Ther 20: 293-301.
42. Zhu J, Huang X, Yang Y, (2009) The TLR9-MyD88 pathway is critical for adaptive immune responses to adeno-associated virus gene therapy vectors in mice. J Clin Invest 119: 2388-2398.
43. Cullen BR, Raymond K, Ju G, (1985) Functional analysis of the transcription control region located within the avian retroviral long terminal repeat. Mol Cell Biol 5: 438-447.
44. Gorman CM, Merlino GT, Willingham MC, Pastan I, Howard BH, (1982) The Rous sarcoma virus long terminal repeat is a strong promoter when introduced into a variety of eukaryotic cells by DNA-mediated transfection. Proc Natl Acad Sci U S A 79: 6777-6781.
45. Okitsu CY, Hsieh C, (2007) DNA methylation dictates histone H3K4 methylation. Mol Cell Biol 27: 2746-2757.
46. Hsieh CL, (1994) Dependence of transcriptional repression on CpG methylation density. Mol Cell Biol 14: 5487-5494.
47. Senigl F, Plachý J, Hejnar J, (2008) The core element of a CpG island protects avian sarcoma and leukosis virus-derived vectors from transcriptional silencing. J Virol 82: 7818-7827.
48. Schnepp BC, Clark KR, Klemanski DL, Pacak CA, Johnson PR, (2003) Genetic fate of recombinant adeno-associated virus vector genomes in muscle. J Virol 77: 3495-3504.
49. Schüttrumpf J, Milanov P, Abriss D, Roth S, Tonn T, et al. (2011) Transgene Loss and Changes in the Promoter Methylation Status as Determinants for Expression Duration in Nonviral Gene Transfer for Factor IX. Hum Gene Ther 22: 101-106.
50. Salva MZ, Himeda CL, Tai PW, Nishiuchi E, Gregorevic P, et al. (2007) Design of tissue-specific regulatory cassettes for high-level rAAV-mediated expression in skeletal and cardiac muscle. Mol Ther 15: 320-329.
51. Robertson KD, Uzvolgyi E, Liang G, Talmadge C, Sumegi J, et al. (1999) The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors. Nucleic Acids Res 27: 2291-2298.
52. Meissner A, (2010) Epigenetic modifications in pluripotent and differentiated cells. Nat Biotechnol 28: 1079-1088.
53. Mobley CM, Sealy L, (1998) Role of the transcription start site core region and transcription factor YY1 in Rous sarcoma virus long terminal repeat promoter activity. J Virol 72: 6592-6601.